Innoviva (INVA) Revenue: 2009-2024
Historic Revenue for Innoviva (INVA) over the last 16 years, with Dec 2024 value amounting to $358.7 million.
- Innoviva's Revenue rose 20.44% to $107.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $209.8 million, marking a year-over-year increase of 9.33%. This contributed to the annual value of $358.7 million for FY2024, which is 15.54% up from last year.
- Innoviva's Revenue amounted to $358.7 million in FY2024, which was up 6,461.39% from $5.5 million recorded in FY2024.
- Over the past 5 years, Innoviva's Revenue peaked at $391.9 million during FY2021, and registered a low of $4.0 million during FY2021.
- Its 3-year average for Revenue is $169.2 million, with a median of $158.0 million in 2023.
- Its Revenue has fluctuated over the past 5 years, first soared by 36.53% in 2022, then declined by 25.60% in 2023.
- Over the past 5 years, Innoviva's Revenue (Yearly) stood at $336.8 million in 2020, then reached $4.0 million in 2021, then rose by 16.35% to $391.9 million in 2021, then skyrocketed by 36.53% to $5.4 million in 2022, then fell by 15.45% to $331.3 million in 2022, then fell by 25.60% to $4.1 million in 2023, then dropped by 6.30% to $310.5 million in 2023, then surged by 34.92% to $5.5 million in 2024, then rose by 15.54% to $358.7 million in 2024.